Yubal, Dasch H.
HRN: 18-91-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2023
MUPIROCIN 2%, 15G (TUBE)
10/26/2023
11/01/2023
TOPICAL
1squirt
BID
Phlebitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes